201/401US=10 / Urologia
McLeod DG, Barqawi. Androgen deprivation for the treatment of prostate cancer: general principles. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 279-84. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; ANDROGENIO; MECANISMO DE ACAO; REGULACAO DO CRESCIMENTO CELULAR


202/401US=10 / Urologia
Kirk D. Hormonal therapy for prostate cancer: optimization and timing. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 285-90. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; TERAPIA HORMONAL; INDICE DE SOBREVIVENCIA; ANDROGENO


203/401US=10 / Urologia
Eisenberger MA. Controversies in hormone treatment for prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 291-4. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; TERAPIA HORMONAL; ABLACAO DE ANDROGENOS


204/401US=10 / Urologia
Garnick MB, Motta C. Androgen deprivation therapy: the future. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 295-306. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; TERAPIA HORMONAL; AGENTES HORMONAIS; TERAPIA DE PRIVACAO DE ANDROGENO


205/401US=10 / Urologia
Gleave M, Goldenberg SL. Intermittent androgen suppression for prostate cancer: rationale and clinical experience. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 307-15. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; SUPRESSAO ANDROGENICA INTERMITENTE


206/401US=10 / Urologia
Beekman KW, Buchanan G, Tilley WD, Scher HI. Antiandrogen withdrawal syndromes: pathophysiology and clinical implications. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 317-25. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; SINDROME DE ABSTINENCIA ANTIANDROGENICO


207/401US=10 / Urologia
Armstrong AJ, Carducci MA. Chemotherapy for advanced prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 327-39. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; QUIMIOTERAPIA; HORMONIO-REFRATARIO; AGENTES BIOLOGICOS


208/401US=10 / Urologia
Song DY, Jabbour SK, DeWeese TL. Radiotherapy for the treatment of locally advanced and metastatic prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 341-57. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; RADIOTERAPIA


209/401US=10 / Urologia
Kirby RS, Coxon JP. Use of bisphosphonates in the management of osseous metastases. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 359-64. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; BISFOSFONATOS; METASTASES OSSEAS


210/401US=10 / Urologia
Kirby RS. Managing the complications of advanced prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 365-74. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; COMPLICACOES; TRATO URINARIO INFERIOR; UROPATIA OBSTRUTIVA; COMPRESSAO DA MEDULA ESPINHAL


211/401US=10 / Urologia
Newling D. Principles of palliative care and psychosocial support of the metastatic prostate cancer patient. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 375-8. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; CUIDADOS PALIATIVOS; APOIO PSICOSSOCIAL; TERAPIA ANTINEOPLASICA; MANEJO DA DOR


212/401US=10 / Urologia
Assikis VJ, Jonas W, Simons JW. The promise of immunotherapy in prostate cancer: from concept to reality. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 379-88. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; IMUNOTERAPIA; VACINA; TECNOLOGIA DE TRANSFERENCIA GENETICA; IMUNOTERAPIA ATIVA; CITOCINAS; IMUNOTERAPIA PASSIVA


213/401US=10 / Urologia
Kirby M. Role of the primary care professional in the care of the patient with prostate cancer: a UK perspective. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 389-94. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; CUIDADO DO PACIENTE; PERSPECTIVA; DIAGNOSTICO; TRIAGEM


214/401US=105 / Câncer
Lamm DL. Bacillus Calmette-Guérin immunotherapy of genitourinary cancer. In: Orentas R, Hodge JW, Johnson BD. Cancer vaccines and tumor immunity. New Jersey: Wiley-Interscience, 2008. p. 29-42. ISBN 978-0-470-07474-9.

CANCER; CANCER GENITO-URINARIO; IMUNOTERAPIA; BACILO CALMETTE-GUERIN; VACINA BCG; TUBERCULOSE; CANCER DE BEXIGA; QUIMIOTERAPIA; CARCINOMA IN SITU; CANCER RENAL; CANCER DE PROSTATA; RESPOSTA IMUNE; TOXICIDADE


215/401US=10 / Dor/Paliativo
McClurg D, McCabe P, Chambers K. Multi-professional management of genitourinary tumours: gynaecological and prostate. In: Rankin J, Robb K, Murtagh N, Cooper J, Lewis S. Rehabilitation in cancer care. New York: John Wiley & Sons, 2008. p. 213-40. ISBN 978-1-4051-5997-5.

TUMORES GENITURINARIOS; CANCERES GINECOLOGICOS; CANCER DE PROSTATA


216/401US=108 / Câncer
Boulanger D, Bateman A. Immunomodulatory gene therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 277-94. ISBN 978-0-470-01922-1.

TERAPIA GENICA; IMUNOMODULADORES; IMUNOTERAPIA; VETORES VIRAIS; TERAPIA DO GENE SUICIDA; VIROTERAPIA; POXVIRUS; VIRUS VACCINIA; AVIPOXVIRUS; ADENOVIRUS; ALPHAVIRUS; VIRUS SEMLIKI FOREST; VIRUS SINDBIS; VIRUS HERPES; ANTIGENO CARCINOEMBRIONARIO; MELANOMA; TIROSINASE; GP100; CANCER COLORRETAL; CANCER DE PROSTATA; PAPILOMAVIRUS HUMANO; HPV


217/401US=103 / Câncer
Boulikas T, Alevizopoulos N. Representative cancers, treatment and market. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 377-86. ISBN 978-0-470-72303-6.

CANCER DE PULMAO; CANCER DE MAMA; CANCER DE PROSTATA; CANCER COLORRETAL; CANCER DE OVARIO; CANCER DE PANCREAS; CANCER GASTRICO; QUIMIOTERAPIA COMBINATORIA; FARMACOS ANTICANCERIGENOS


218/401US=110 / Câncer
Wahl RL. Imaging. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 283-308. ISBN 978-0-443-06695-5.

NEOPLASIA; CANCER; IMAGEM; TIPOS DE IMAGEM; IMAGEM ANATOMICA; IMAGEM FUNCIONAL; CANCER DE PULMAO; CANCER DE MAMA; CANCER DE PROSTATA; CANCER DE COLON; NEOPLASIAS GINECOLOGICAS; LINFOMA; MELANOMA; CARCINOMA DE BEXIGA; CANCER DE CABECA E PESCOCO; CARCINOMA PANCREATICO; CANCER DE FIGADO; CANCER DE RIM; TUMORES ENDOCRINOS; TUMORES CEREBRAIS


219/401US=110 / Câncer
Zell JA, Meyskens FL. Cancer prevention, screening, and early detection. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 361-94. ISBN 978-0-443-06695-5.

NEOPLASIAS; CANCER; PREVENCAO DO CANCER; DETECCAO PRECOCE; MALIGNIDADES AERODIGESTIVAS; CANCER COLORRETAL; CANCER DE MAMA; CANCER DE PROSTATA; CANCER DE PELE; CANCER DE OVARIO; CANCER CERVICAL


220/401US=110 / Câncer
Nelson WG, Carter B, DeWeese T, Eisenberger MA. Prostate cancer. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 1653-99. ISBN 978-0-443-06695-5.

CANCER DE PROSTATA


Primeira | Anterior | Próxima | Última